Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide

August 27, 2015 updated by: Mibelle AG

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide: a Mono-centre, Not-controlled. Not Blinded, Not-randmised in Situ Study

In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.

Study Overview

Status

Withdrawn

Detailed Description

The primary objective of the study is the detection of the Curolox™ peptide on the bovine enamel sample (proof-of-concept) under in vivo conditions after rinsing with the peptide-containing mouth wash.

Secondary Objectives

The secondary objectives of the study are:

  1. safety and tolerance of the mouthwash in participants
  2. identification of the duration the Curolox™ peptide is present on the bovine tooth surface under in vivo conditions
  3. identification of the most effective mouthwash rinsing volume (2.5 mL or 5 mL)
  4. prophylactic effect of multiple applications of the mouthwash confirmation of the prophylactic effect of the Curolox™ peptide obtained in in vitro study

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Willing and able to understand and to follow the study procedures and instructions
  • Willing to wear a dental appliance for 7 days
  • Willing and able to attend the on-study visits
  • Good oral hygiene throughout the study
  • Written informed consent before participation in the study

Exclusion Criteria:

  • Volunteer with an active periodontal disease or periodontal surgery < 1 year prior to study participation
  • Volunteer with hypersensitive teeth or with any other (painful) oral pathology or defect
  • Volunteer with an orthodontic appliance
  • Volunteer undergoing a medical treatment
  • Volunteer who is allergic to dental products
  • Pregnant and lactating woman
  • Concurrent participation in another clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Candida Mouthwash with Curolox™ Peptide
Repeated applications 2.5 ml or 5 ml twice daily
Prophylaxis - protection and care of teeth against caries & acidic challenges
Other Names:
  • Candida Protect

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of Curolox peptide by mass spectroscopy
Time Frame: Immediately after rinsing with the mouthwash
The primary outcome is the detection of the Curolox™ peptide on the bovine enamel sample immediately after rinsing with the peptide-containing mouth wash by mass spectroscopy
Immediately after rinsing with the mouthwash

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of Curolox peptide by mass spectroscopy
Time Frame: 12 hours, 24 hours, 48 hours, 96 hours
The secondary outcome is the detection of the Curolox™ peptide on the bovine enamel sample 12 hours, 24 hours, 48 hours and 96 hours after rinsing with the peptide-containing mouth wash by mass spectroscopy
12 hours, 24 hours, 48 hours, 96 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Christian Besimo, Dr.med.dent., Aeskulap Klinik
  • Study Director: Ulrich P. Saxer, Dr.med.dent., Aeskulap Klinik / PZZN

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Anticipated)

March 1, 2015

Study Completion (Anticipated)

March 1, 2015

Study Registration Dates

First Submitted

November 27, 2014

First Submitted That Met QC Criteria

December 2, 2014

First Posted (Estimate)

December 4, 2014

Study Record Updates

Last Update Posted (Estimate)

August 28, 2015

Last Update Submitted That Met QC Criteria

August 27, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • P11-4-MW15.042

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erosion of Teeth, Unspecified

3
Subscribe